CM
EVH icon

Castleark Management’s Evolent Health EVH Stock Holding History

Castleark Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-168,180
Closed -$5.46M – 290
2023
Q1 		$5.46M Buy
168,180
+16,570
+11% +$524K 0.27% 88
2022
Q4 		$4.26M Buy
151,610
+33,040
+28% +$947K 0.22% 108
2022
Q3 		$4.26M Buy
+118,570
New +$4.18M 0.24% 110
2018
Q4 		– Sell
-479,360
Closed -$13.6M – 381
2018
Q3 		$13.6M Buy
+479,360
New +$11.4M 0.39% 86
2017
Q3 		– Sell
-564,057
Closed -$14.3M – 396
2017
Q2 		$14.3M Buy
+564,057
New +$13.6M 0.47% 56
2016
Q4 		– Sell
-397,884
Closed -$9.8M – 392
2016
Q3 		$9.8M Buy
+397,884
New +$9.3M 0.3% 97

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Castleark Management's EVH Position: Q2 2023 in Review

Castleark Management sold out of Evolent Health (EVH) in Q2 2023, closing a stake of 168,180 shares — an estimated $5.46M sold.

Castleark Management first reported a position in EVH in Q3 2016 and held it in 6 quarters. The position peaked at $14.3M in Q2 2017. 217 funds tracked by Wall St. Rank hold EVH as of Q2 2023.

  • Castleark Management reported no remaining Evolent Health position as of Q2 2023 after selling out during the quarter.
  • Castleark Management sold 168,180 Evolent Health shares in Q2 2023, an estimated $5.46M.
  • Castleark Management first reported a position in Evolent Health in Q3 2016 and held it in 6 quarters.
  • Castleark Management's Evolent Health position peaked at $14.3M in Q2 2017.
  • 217 funds tracked by Wall St. Rank held Evolent Health as of Q2 2023.

Based on Castleark Management's 13F filing for Q2 2023, filed 16 Aug 2023.